Aptamer-target interaction descriptor
Aptamer-target interaction information
Interaction ID: 942
Aptamer sequence: UGGGCCGGAGGUUAGCUUGCCCAUGGCAAGCAGGGCGCCACGGACCCA
Target unique ID: Other-5
Aptamer ID Aptamer descriptor Target chemistry Target name Affinity Binding Conditions/Buffer PubMed ID
Apta_856 SE RNA Other Anti-acetylcholine Autoantibodies 60 nM 30 mM Tris-HCl (pH 7.5), 150 mM NaCl, 10 mM MgCl2, 2 mM DTT, 1% BSA 9035104
Structure information of aptamer
Aptamer Sequence: UGGGCCGGAGGUUAGCUUGCCCAUGGCAAGCAGGGCGCCACGGACCCA
The optimal secondary structure in dot-bracket notation: (((((((..(((..(((((((...))))))).....))).))).))))
The centroid secondary structure in dot-bracket notation: (((((((..((((.(((((((...)))))))..)..))).))).))))
The MFE structure
The Centroid structure
The mountain plot representation
Aptamer information
Type Detail Type Detail
Aptamer ID Apta_856 Description SE RNA
Aptamer chemistry RNA Length 48 nt
GC content 68.8% Molecular weight 15,529.31 Da
Molarity of 1 μg/μl solution 64.39 μM Number of G-quadruplexes No QGRS found
G-Score N/A Function Targeted binding
Sequence UGGGCCGGAGGUUAGCUUGCCCAUGGCAAGCAGGGCGCCACGGACCCA
Applications Protect acetylcholine receptors on human cells from the effects of these antibodies.
Target information
Type Detail Type Detail
Target ID Other-5 Name Anti-acetylcholine Autoantibodies
Activity data
Interaction ID 942
Target type Other
Target unique ID Other-5
Activity 60 nM
Binding Conditions/Buffer

30 mM Tris-HCl (pH 7.5), 150 mM NaCl, 10 mM MgCl2, 2 mM DTT, 1% BSA

Assay

Binding affinity

PubMed ID 9035104
Interaction ID 972
Target type Other
Target unique ID Other-19
Activity 60 nM
Binding Conditions/Buffer

30 mM Tris-HCl (pH 7.5), 150 mM NaCl, 10mM MgCl2, 2mM dithiothreitol, 1% BSA

Assay

Binding affinity

PubMed ID 9035104
Similar aptamers
Aptamer ID Aptamer chemistry Sequence Similarity
Apta_366 RNA GGUUAGAGGCGACGUCCCGGAAUCCGCGCCCAUUGCCCCC 56.25%
Apta_367 RNA CGAGCGUAGAAUGUCUUCCCACUAGACGUCGUUCGGCCCC 56.25%
Apta_660 RNA UGGGAGGAGUGCUGCUCUCCAGGCACUCUUGUUGCUCGGA 56.25%
Apta_365 RNA GGACCUAUGCAGUAGCCAGUGUGGACUGGGCUGCCCCCCC 54.17%
Apta_658 RNA CUGCGAUCAGGGGUAAAUUUCCGCGCAGGCUCCACGCCGC 54.17%
Apta_460 RNA GGAUGGCAGCGGAGAGUUGCUUGGAAUGCGUUAUAGUCUCUUAGGUGUGUACAGCCCACACCACUCUCC 53.62%
Apta_133 RNA GGGAGGACGAUGCGGUGAGUCGUUCCCUUCGUCCCCAGACGACUCGCCCGA 52.94%
Apta_3 DNA CCTGCCTTTGGCAGCCGGGCGAAGGCAACCCGACACCGACAGC 52.08%
Apta_521 RNA GGGUUGGGAAGAAACUGUGGCACUUCGGUGCCAGCAACCC 52.08%
Apta_703 RNA GGGCGGAUGAGACGCUUGGCGUGUGCUGUGGAGAGUCAUCCG 52.08%
Apta_256 RNA GGGCGCUAAGUCCUCGCUCAUGCGCGUCCCAUGGGGUAUAGAGGGGUCGAAGUGGACGCGCGACUCGGAUCCU 52.05%
Apta_38 RNA GGUAGAUACGAUGGAUACCCCCUGUGGCCCGUCAACACAGGGGAAGUGGCAUGACGCGCAGCCA 51.56%
Apta_645 RNA CUGGACGACGGGGACGCCACUGGACUAGGUAAGCCAGGACCGUACGUCGGGAGCCGUCAGAAUA 51.56%
Apta_315 RNA GGGAGGACGAUGCGGUCGUAUUAUCCGCUGCACGCCAGACGACUCGCCCGA 50.98%
Apta_2 RNA GGGCUUCUCUGGUUAGACCAGAUUUGAGCCUGGGAGCUCUCUGGCUAACUAGGGAACCC 50.85%
Apta_130 RNA GGGAGGACGAUGCGGUGGUAGCGCGAUAUAGCGCUGGUAGGGUUGCCGGUGAUCAGACGACUCGCCCGA 50.72%
Apta_353 RNA GAAUUCCGCGUGUGCCAGCGAAAGUUGCGUAUGGGUCACAUCGCAGGCACAUGUCAUCUGGGCGGUCCGUUCGGGAUCC 50.63%
Apta_218 RNA AGCCGCGAGGGGAGGGAUAGGGUAGGGCGCGGCU 50.00%
Apta_303 RNA CCUCCGGCUCAUACCUUUUCGAAGACAAGCUUCGACAGGAGG 50.00%
Apta_305 RNA GGGAGGACGAUGCGGAUCGCCCUGAACCGGCCCAGCAGACUGCUGACGGCACGAUCCGCAUCGUCCUCCC 50.00%